In Other News

• Novel Rapid Lateral Flow Immunoassay Can Function as `Suitcase Laboratory` for On-Site Detection of COVID-19

• Ground-Breaking AI Platform Helps Find Best Combination of Available Therapies against COVID-19

• Chinese Firm Sinopharm’s COVID-19 Vaccine Shows 86% Efficacy in Late-Stage Trials

• Thermo Fisher’s New Direct from Saliva PCR Test for COVID-19 Enables Fast, Low-Cost Results

• Roche Partners with Moderna for Use of Its SARS-CoV-2 Antibody Test in COVID-19 Vaccine Trials

• EKF Launches One of the First Tests to Precisely Measure Levels of COVID-19 Neutralizing Antibodies

• Handheld COVID-19 Disinfecting Wand Kills 99.9% of SARS-CoV-2 in 10 Seconds

• Digital Spatial Profiler Identifies Diverse Immune Responses within COVID-19 Patients

• COVID-19 Test Uses `Lab at Your Fingertip` Technology to Measure SARS-CoV-2 Antibodies in 15 Minutes

• COVID-19 Diagnostics Market to Surpass Revenues of USD 13 Billion in 2020

• Ultra-Specific, Non-Invasive Saliva Test Enables Quantitative Testing Of COVID-19 Antibodies

• CorVent Medical’s RESPOND-19 Ventilator Receives FDA Emergency Use Authorization for Multiple Patient Use

• Minimally-Invasive, Point-of-Care Test for COVID-19 Patients Assesses Disease Progression

• High-Speed NanoPCR Technology Diagnoses COVID-19 in 20 Minutes with Zero False Positive and False Negative

• Rapid, Ultrasensitive Test Uses Paper-Based Electrochemical Sensor to Detect COVID-19 in Five Minutes

• New COVID-19 Testing Approach That Measures Immune Response Can Be Combined with Standard PCR Tests for Accurate Diagnosis

• New Blood Test for Early Immune Response to SARS-CoV-2 Could Enable Early Detection of Serious COVID-19 Patients

• Low-Cost, Easy to Use COVID-19 Saliva Test Provides Accurate Results within 30 Minutes

• Global Viral RNA Extraction Kit Market to Continue Being Driven by COVID-19 Pandemic

• QIAGEN Launches QuantiFERON SARS-CoV-2 RUO Solution That Detects T-Cell Response to Novel Coronavirus

• Lumin UV System Receives FDA EUA for SARS-CoV-2 N95 Re-Use in Nursing Homes, Ambulatory Care and Primary Care

• FDA Authorizes First COVID-19 and Flu Combination Test for Use with Home-Collected Samples

• Moderna COVID-19 Vaccine Provides Immunity for Three Months, Shows New NIAID Study